Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at having imatinib with or without surgery for gastrointestinal stromal tumours (EORTC 62063)
Cancer type:
Sarcoma
Soft tissue sarcoma
Status:
Results
Phase:
Phase 3
This trial was looking at having surgery with imatinib for gastrointestinal stromal tumours. The trial was for gastrointestinal stromal tumours (GIST) that had spread locally or to the liver.
Doctors often treat GIST that has spread with imatinib, and it stops the cancer coming back for a while. Doctors are always looking for ways to increase the amount of time before the GIST starts to come back. They thought that having surgery, as well as imatinib may help.
The aim of this trial was to see if adding surgery to imatinib could increase the amount of time before GIST started to come back.
Summary of results
This trial was never finished so there are no results available. The researchers were unable to recruit enough patients.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Dr Michael Leahy
Supported by
European Organisation for Research and Treatment of Cancer (EORTC)
NIHR Clinical Research Network: Cancer
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
Oracle 5589
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Around 1 in 5 people take part in clinical trials
